康希诺生物(06185.HK) 公布第一季度报告,按中国会计准则,实现营业收入1.37亿人民币(下同),按年增加20%。亏损由上年同期1.7亿,收窄至1,155万元,每股亏损5分。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-29 16:25。)过往派息公布日期派息事项派息内容2025/03/25末期业绩无派息2024/10/29第三季业绩无派息2024/08/29中期业绩...
Source Link康希诺生物(06185.HK) 公布第一季度报告,按中国会计准则,实现营业收入1.37亿人民币(下同),按年增加20%。亏损由上年同期1.7亿,收窄至1,155万元,每股亏损5分。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-29 16:25。)过往派息公布日期派息事项派息内容2025/03/25末期业绩无派息2024/10/29第三季业绩无派息2024/08/29中期业绩...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.